This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopah [2025/01/29 23:11] – [Biological function] jfpothier | bacteria:t3e:xopah [2025/08/04 09:40] (current) – [The Type III Effector XopAH from //Xanthomonas//] rkoebnik | ||
---|---|---|---|
Line 2: | Line 2: | ||
Author: [[https:// | Author: [[https:// | ||
- | Internal reviewer: [[https:// | + | Internal reviewer: [[https:// |
+ | Expert reviewer: [[https:// | ||
Class: XopAH\\ | Class: XopAH\\ | ||
Line 16: | Line 17: | ||
=== How discovered? === | === How discovered? === | ||
- | AvrXccC was described during a genome comparison analysis between // | + | AvrXccC was described during a genome comparison analysis between // |
+ | The homolog in // | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
Secreted XopAH (AvrXccC) proteins were detected in culture fluid from //Xcc// 8004 and //hrcV// mutant complemented strains but not from the //hrcV// mutant (Wang //et al//., 2007). Insertion and deletion mutants affecting the locus (Xcc2109) in the type strain (Xcc 528) resulted in loss of virulence on the host Florida Broad Leaf Mustard (Castañeda //et al//., 2005). | Secreted XopAH (AvrXccC) proteins were detected in culture fluid from //Xcc// 8004 and //hrcV// mutant complemented strains but not from the //hrcV// mutant (Wang //et al//., 2007). Insertion and deletion mutants affecting the locus (Xcc2109) in the type strain (Xcc 528) resulted in loss of virulence on the host Florida Broad Leaf Mustard (Castañeda //et al//., 2005). | ||
+ | The homolog in //X. hyacinthi// strain CFBP 1156 (FZ025_RS19665), | ||
=== Regulation === | === Regulation === | ||
Promoter activity assays showed that the expression of XopAH (// | Promoter activity assays showed that the expression of XopAH (// | ||
+ | The presence of a PIP box and a properly spaced ‐10 promoter motif (TTCGB‐N< | ||
=== Phenotypes === | === Phenotypes === | ||
- | This effector | + | AvrXccC |
- | + | ||
- | In the interaction // | + | |
+ | In the interaction // | ||
=== Localization === | === Localization === | ||
- | XopAH (AvrXccC) is anchored to the plant plasma membrane, and the N‐terminal myristoylation site (amino acids 2–7: GLcaSK) is essential for its localization (Wang //et al//., 2007). | + | XopAH (AvrXccC) is anchored to the plant plasma membrane, and the N‐terminal myristoylation site (amino acids 2–7: GLcaSK) is essential for its localization (Wang //et al.//, 2007). |
+ | The presence of conserved myristoylation and palmitoylation signals at the N terminus of XopAH (FZ025_RS19665) suggests again that the protein is localized to the plasma membrane in the plant host cell (Nimchuk //et al.//, 2000; Thieme //et al.//, 2007). | ||
=== Enzymatic function === | === Enzymatic function === | ||
- | XopAH has a Fido/AvrB domain derived from the fic (cyclic adenosine monophosphate (cAMP)-induced filamentation and doc (death on curing) domains (Kinch //et al//., 2009). Structural comparisons resulted in the inclusion of similar segments of the T3 effector AvrB from // | + | XopAH has a Fido/AvrB domain derived from the fic (cyclic adenosine monophosphate (cAMP)-induced filamentation and doc (death on curing) domains (Kinch //et al//., 2009). Structural comparisons resulted in the inclusion of similar segments of the T3 effector AvrB from // |
=== Interaction partners === | === Interaction partners === | ||
- | Not known ? | + | Not known. |
===== Conservation ===== | ===== Conservation ===== | ||
Line 48: | Line 51: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | In // | + | In // |
+ | |||
+ | But also conserved in //X. hyacinthi//, | ||
=== In other plant pathogens/ | === In other plant pathogens/ | ||
Yes (AvrB // | Yes (AvrB // | ||
+ | |||
+ | But also conserved in // | ||
+ | |||
===== References ===== | ===== References ===== | ||
Line 67: | Line 75: | ||
Kinch LN, Yarbrough ML, Orth K, Grishin NV (2009). Fido, a novel AMPylation domain common to Fic, Doc, and AvrB. PLoS One 4: e5818. DOI: [[https:// | Kinch LN, Yarbrough ML, Orth K, Grishin NV (2009). Fido, a novel AMPylation domain common to Fic, Doc, and AvrB. PLoS One 4: e5818. DOI: [[https:// | ||
+ | |||
+ | Koebnik R, Krüger A, Thieme F, Urban A, Bonas U (2006). Specific binding of the // | ||
Lee CC, Wood MD, Ng K, Andersen CB, Liu Y, Luginbühl P, Spraggon G, Katagiri F (2004). Crystal structure of the type III effector AvrB from // | Lee CC, Wood MD, Ng K, Andersen CB, Liu Y, Luginbühl P, Spraggon G, Katagiri F (2004). Crystal structure of the type III effector AvrB from // | ||
+ | |||
+ | Nimchuk Z, Marois E, Kjemtrup S, Leister RT, Katagiri F, Dangl JL (2000). Eukaryotic fatty acylation drives plasma membrane targeting and enhances function of several type III effector proteins from Pseudomonas syringae. Cell 101: 353-363. DOI: [[https:// | ||
+ | |||
+ | Passelergue A (2025). Discovery of eight type III effector genes harboring the PIP box in clade-I xanthomonads. Master' | ||
Qian W, Jia Y, Ren SX, He Y Q, Feng JX, Lu LF, Sun Q, Ying G, Tang DJ, Tang H, Wu W, Hao P, Wang L, Jiang BL, Zeng S, Gu WY, Lu G, Rong L, Tian Y, Yao Z, Fu G, Chen B, Fang R, Qiang B, Chen Z, Zhao GP, Tang JL, He C (2005). Comparative and functional genomic analyses of the pathogenicity of phytopathogen // | Qian W, Jia Y, Ren SX, He Y Q, Feng JX, Lu LF, Sun Q, Ying G, Tang DJ, Tang H, Wu W, Hao P, Wang L, Jiang BL, Zeng S, Gu WY, Lu G, Rong L, Tian Y, Yao Z, Fu G, Chen B, Fang R, Qiang B, Chen Z, Zhao GP, Tang JL, He C (2005). Comparative and functional genomic analyses of the pathogenicity of phytopathogen // | ||
+ | |||
+ | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | ||
+ | |||
+ | Wagner N, Baumer E, Lyubman I, Shimony Y, Bracha N, Martins L, Potnis N, Chang JH, Teper D, Koebnik R, Pupko T (2025). Effectidor II: a pan-genomic AI-based algorithm for the prediction of type III secretion system effectors. Bioinformatics 41: btaf272. DOI: [[https:// | ||
Wang L, Tang X, He C (2007). The bifunctional effector AvrXccC of // | Wang L, Tang X, He C (2007). The bifunctional effector AvrXccC of // | ||
+ | |||
+ | Wengelnik K, Bonas U (1996). HrpXv, an AraC-type regulator, activates expression of five of the six loci in the hrp cluster of // | ||
+ | |||
+ | Wengelnik K, Van den Ackerveken G, Bonas U (1996). HrpG, a key hrp regulatory protein of // | ||
White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||
+ | |||
+ | Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL effectors in // | ||
===== Acknowledgements ===== | ===== Acknowledgements ===== |